Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 7/20 | 0.50 |
| ▸ | PPARD | Q03181 | 7/20 | 0.50 |
| ▸ | PPARA | Q07869 | 7/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | FABP4 | P15090 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19946360 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4597396 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL15253969 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL30897212 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL6678271 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL19946361 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL6678274 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5367890 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4597394 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL3122384 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611816-B1 | PREPARATION OF PHOSPHORUS-CONTAINING ANTIWEAR COMPOUNDS FOR USE IN LUBRICANT COMPOSITIONS | LUBRIZOL CORP (US) | 2017-07-26 | — | — | EP | claimed |
| US-11998517-B2 | Antimicrobial composition | ROTTAPHARM SPA (IT) | 2024-06-04 | — | — | US | disclosed |
| CN-114246956-A | Oxygen-deficient iron-molybdenum oxide flower-like nanoparticles for diagnosis and treatment integration and preparation method and application thereof | 重庆医科大学附属第一医院 | 2022-03-29 | — | — | CN | disclosed |
| US-11168278-B2 | Alkyl phosphate amine salts for use in lubricants | THE LUBRIZOL CORPORATION (US) | 2021-11-09 | — | — | US | disclosed |
| US-20210121424-A1 | ANTIMICROBIAL COMPOSITION | ROTTAPHARM SPA (IT) | 2021-04-29 | — | — | US | disclosed |
| US-10912747-B2 | Antimicrobial composition | ROTTAPHARM SPA | 2021-02-09 | — | — | US | disclosed |
| US-20190247341-A1 | ANTIMICROBIAL COMPOSITION | ROTTAPHARM SPA (IT) | 2019-08-15 | — | — | US | disclosed |
| US-20190241825-A1 | ALKYL PHOSPHATE AMINE SALTS FOR USE IN LUBRICANTS | THE LUBRIZOL CORPORATION (US) | 2019-08-08 | — | — | US | disclosed |
| EP-3487966-A1 | ALKYL PHOSPHATE AMINE SALTS FOR USE IN LUBRICANTS | The Lubrizol Corporation (US) | 2019-05-29 | — | — | EP | disclosed |
| EP-3292758-A1 | ANTIMICROBIAL COMPOSITION COMPRISING A CARBOXYLIC ACID AND TWO DIOLS | Rottapharm S.p.A. (IT) | 2018-03-14 | — | — | EP | disclosed |
| WO-2018017449-A1 | ALKYL PHOSPHATE AMINE SALTS FOR USE IN LUBRICANTS | THE LUBRIZOL CORPORATION (US) | 2018-01-25 | — | — | WO | disclosed |
| EP-2611816-B1 | PREPARATION OF PHOSPHORUS-CONTAINING ANTIWEAR COMPOUNDS FOR USE IN LUBRICANT COMPOSITIONS | LUBRIZOL CORP (US) | 2017-07-26 | — | — | EP | disclosed |
| US-20170137740-A1 | Functionalised Copolymers and Lubricating Compositions Thereof | LUBRIZOL CORP (US) | 2017-05-18 | — | — | US | disclosed |
| EP-2669356-B1 | Lubricating composition | LUBRIZOL CORP (US) | 2016-11-02 | — | — | EP | disclosed |
| US-9382275-B2 | Preparation of phosphorus—containing antiwear composition for use in lubricant compositions | THE LUBRIZOL CORPORATION (US) | 2016-07-05 | — | — | US | disclosed |
| US-20150307527-A1 | Preparation of Phosphorus - Containing Antiwear Composition for Use in Lubricant Compositions | THE LUBRIZOL CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |
| EP-2669356-A1 | Functionalised copolymers and lubricating compositions thereof | The Lubrizol Corporation (US) | 2013-12-04 | — | — | EP | disclosed |
| US-20130244918-A1 | Functionalized Copolymers And Lubricating Compositions Thereof | THE LUBRIZOL CORPORATION (US) | 2013-09-19 | — | — | US | disclosed |
| EP-1671936-B1 | Process for synthetizing paraffinic diols and triols possessing a vicinal diol group | DEGUSSA (DE) | 2007-10-31 | — | — | EP | disclosed |
| EP-1671936-A2 | Process for synthetizing paraffinic diols and triols possessing a vicinal diol group | Degussa AG (DE) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150307527-A1 | Preparation of Phosphorus - Containing Antiwear Composition for Use in Lubricant Compositions | PHOSPHO1, NAPEPLD, POLR1C | GPR84 1959/4885PPARG 759/4885PPARD 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.